铁亡作为与年龄相关的黄斑退化症的潜在治疗标
Dongcheng Liu1, Ziling Liu1, Hongxia Liao1
1Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China; Shenzhen Aier Ophthalmic Technology Institute, Shenzhen, China.
Drug discovery today
|February 18, 2024
概括
铁亡是一种细胞死亡形式,涉及铁和脂质过氧化物,是与年龄相关的黄斑变性 (AMD) 进展的关键. 通过保护视网膜细胞,抑制铁亡对治疗AMD有希望.
科学领域:
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
- 与年龄相关的黄斑退化症的发病原因
背景情况:
- 细胞死亡是与年龄相关的黄斑变性 (AMD) 病原体的组成部分,但机制尚未完全理解.
- 新出现的证据表明,铁亡,一种依赖铁的细胞死亡途径,标志着脂质氧化的积累,在AMD中.
- 铁致死有助于视网膜细胞的降解,并加速AMD的进展.
研究的目的:
- 审查AMD中铁亡的分子机制.
- 为了确定潜在的铁灭抑制剂用于AMD治疗.
- 讨论针对AMD治疗性治疗ferroptosis的挑战和机会.
主要方法:
- 对铁和AMD研究的文献综述.
- 对涉及铁灭的分子通路的分析.
- 对现有和潜在的铁灭抑制剂的评估.
主要成果:
- 铁亡是AMD视网膜细胞死亡的重要贡献者.
- 铁灭抑制剂在AMD模型中表现出保护作用.
- 向铁亡是一种有前途的AMD治疗途径.
结论:
- 铁亡是一个关键的机制驱动视网膜细胞死亡在AMD.
- 针对铁亡的治疗策略可以为AMD提供新的治疗方法.
- 需要进一步的研究,以克服ferroptosis抑制剂临床应用中的挑战.
关键词:
与年龄相关的黄斑变性.铁性化 (ferroptosis) 是一种铁是铁,铁是铁,铁是铁.脂类过氧化过氧化保护作用保护效果有活性氧物种的反应性氧物种.调节细胞死亡的调节细胞死亡.治疗目标是治疗的目标.更多相关视频
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.0K
06:16Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
2.5K
相关概念视频
01:16Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K